From the collected supernatant, we found that cetuximab-activated NK cells by PD-1 tended to be inactivated by the overexpression of PD-L1 (programmed death ligand 1) in the HNSCC TME. This evidence concerns the gene CD274 and head and neck squamous cell carcinoma.